as 07-26-2024 4:00pm EST
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Stryker Corporation SYK prepares to release earnings report on 30 Jul 2024.
Founded: | 1941 | Country: | United States |
Employees: | N/A | City: | KALAMAZOO |
Market Cap: | 129.9B | IPO Year: | N/A |
Target Price: | $372.72 | AVG Volume (30 days): | 1.1M |
Analyst Decision: | Strong Buy | Number of Analysts: | 18 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 8.76 | EPS Growth: | 27.51 |
52 Week Low/High: | $249.98 - $361.41 | Next Earning Date: | 07-30-2024 |
Revenue: | $20,963,000,000 | Revenue Growth: | 10.61% |
Revenue Growth (this year): | 9.94% | Revenue Growth (next year): | 7.75% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Fletcher Robert S | SYK | VP, Chief Legal Officer | May 22 '24 | Sell | $332.99 | 2,007 | $668,307.92 | 8,896 | SEC Form 4 |
Boehnlein Glenn S | SYK | VP, Chief Financial Officer | May 15 '24 | Sell | $327.65 | 10,000 | $3,276,516.00 | 15,012 | SEC Form 4 |
Berry William E Jr | SYK | VP, Chief Accounting Officer | Mar 7 '24 | Sell | $358.48 | 7,690 | $2,756,729.66 | 3,675 | SEC Form 4 |
Boehnlein Glenn S | SYK | VP, Chief Financial Officer | Feb 9 '24 | Sell | $342.81 | 9,600 | $3,290,952.00 | 20,194 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $341.97 | 566 | $193,555.02 | 3,665,032 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $343.45 | 1,000 | $343,450.00 | 3,664,032 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $344.47 | 1,200 | $413,364.00 | 3,662,832 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $341.45 | 31,071 | $10,609,192.95 | 3,925,203 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $342.37 | 69,691 | $23,860,107.67 | 3,855,512 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $343.05 | 63,777 | $21,878,699.85 | 3,791,735 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $344.33 | 18,748 | $6,455,498.84 | 3,772,987 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $345.41 | 15,853 | $5,475,784.73 | 3,757,134 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $346.00 | 2,006 | $694,076.00 | 3,755,128 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $339.47 | 54,696 | $18,567,651.12 | 3,700,432 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $340.28 | 29,626 | $10,081,135.28 | 3,670,806 | SEC Form 4 |
STRYKER RONDA E | SYK | Director10% Owner | Feb 5 '24 | Sell | $341.18 | 5,208 | $1,776,865.44 | 3,665,598 | SEC Form 4 |
Golston Allan C. | SYK | Director | Feb 2 '24 | Sell | $341.00 | 3,273 | $1,116,093.00 | 14,242 | SEC Form 4 |
Datar Srikant M. | SYK | Director | Dec 1 '23 | Sell | $298.22 | 500 | $149,111.50 | 3,816 | SEC Form 4 |
Berry William E Jr | SYK | VP, Chief Accounting Officer | Nov 28 '23 | Sell | $292.28 | 573 | $167,476.73 | 2,909 | SEC Form 4 |
Lobo Kevin | SYK | Chair and CEO | Nov 17 '23 | Sell | $287.42 | 32,857 | $9,443,712.94 | 104,660 | SEC Form 4 |
Lobo Kevin | SYK | Chair and CEO | Nov 17 '23 | Sell | $288.26 | 15,092 | $4,350,407.85 | 89,568 | SEC Form 4 |
Lobo Kevin | SYK | Chair and CEO | Nov 17 '23 | Sell | $289.12 | 8,060 | $2,330,284.63 | 81,508 | SEC Form 4 |
Lobo Kevin | SYK | Chair and CEO | Nov 17 '23 | Sell | $289.89 | 474 | $137,406.11 | 81,034 | SEC Form 4 |
Datar Srikant M. | SYK | Director | Nov 14 '23 | Sell | $287.57 | 750 | $215,681.03 | 5,316 | SEC Form 4 |
Datar Srikant M. | SYK | Director | Nov 14 '23 | Sell | $287.50 | 500 | $143,751.00 | 4,816 | SEC Form 4 |
SYK Breaking Stock News: Dive into SYK Ticker-Specific Updates for Smart Investing
Zacks
11 hours ago
Zacks
4 days ago
Simply Wall St.
9 days ago
Zacks
10 days ago
Zacks
10 days ago
Zacks
10 days ago
Zacks
11 days ago
Medical Device Network
11 days ago
The information presented on this page, "SYK Stryker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.